- Home
- GNTA vs FSEA Comparison
GNTA vs FSEA Comparison
Compare GNTA & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNTA | FSEA |
|---|---|---|
| Founded | 2014 | 1890 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 61.5M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GNTA | FSEA |
|---|---|---|
| Price | $0.84 | $12.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 73.9K | 3.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $10.13 |
| 52 Week High | $10.00 | $15.00 |
Technical Indicators
Market Signals| Indicator | GNTA | FSEA |
|---|---|---|
| Relative Strength Index (RSI) | 37.54 | 45.59 |
| Support Level | $0.71 | $11.44 |
| Resistance Level | $1.70 | $13.00 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 9.87 | 7.03 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.